TrialCancer research and treatment2020

Ramosetron versus Palonosetron in Combination with Aprepitant and Dexamethasone for the Control of Highly-Emetogenic Chemotherapy-Induced Nausea and Vomiting.

Jin Hyoung Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.